Systemic lupus erythematosus vaccine (Abraxis BioScience/MedClone)

N/A

Report date: 2022/03/01 14:18:08

Base Information

Drug NameSystemic lupus erythematosus vaccine (Abraxis BioScience/MedClone)
Drug Alias Name3E10 vaccineMonoclonal antibody 3E103E10 - American Bioscience/MedCloneLupus nephritis vaccine - American Bioscience/MedClone
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLupus Erythematosus, SystemicLupus Nephritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbraxis Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbraxis Bioscience Inc
Active IndicationsN/A
Inactive IndicationsLupus Erythematosus, SystemicLupus Nephritis

Other Information

ATC CodeN/A
Related LinksN/A